BRAIN Biotech AG (BNN.DE)
EUR 3.77
(-3.58%)
EUR 3.77
(-3.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 55.33 Million | 49.5 Million | 38.38 Million | 38.22 Million | 38.56 Million | 27.05 Million |
| Cost of Revenue | 25.21 Million | 22.06 Million | 16.81 Million | 17.02 Million | 17.44 Million | 13.66 Million |
| Gross Profit | 30.12 Million | 27.44 Million | 21.57 Million | 21.2 Million | 21.11 Million | 13.39 Million |
| Operating Expenses | 24.94 Million | 34.33 Million | 29.4 Million | 29.18 Million | 26.76 Million | 23.43 Million |
| Selling, General and Administrative Expenses | 5.38 Million | 4.29 Million | 2.71 Million | 3.32 Million | 3.66 Million | 4.04 Million |
| Research and Development Expenses | 4.97 Million | 4.87 Million | 5.38 Million | 5.78 Million | 7.82 Million | 7.57 Million |
| Other Expenses | 118 Thousand | 30.03 Million | 26.68 Million | 25.85 Million | 23.1 Million | 19.38 Million |
| Cost and Expenses | 62.05 Million | 56.39 Million | 46.22 Million | 46.21 Million | 44.21 Million | 37.09 Million |
| Operating Income | -6.71 Million | -6.88 Million | -7.83 Million | -7.98 Million | -5.65 Million | -10.04 Million |
| Interest Expense | 942 Thousand | 249 Thousand | 236 Thousand | 388 Thousand | 228 Thousand | 164 Thousand |
| Income Tax Expense | 625 Thousand | 176 Thousand | 403 Thousand | -927 Thousand | 9000.00 | -219 Thousand |
| Earnings before Tax | -7.48 Million | -6.16 Million | -4.27 Million | -9.94 Million | -10.48 Million | -8.49 Million |
| Net Income | -8.27 Million | -6.34 Million | -4.67 Million | -9.01 Million | -10.49 Million | -8.27 Million |
| Earnings Per Share Basic | -0.38 | -0.29 | -0.23 | -0.48 | -0.58 | -0.46 |
| Earnings Per Share Diluted | -0.38 | -0.29 | -0.23 | -0.48 | -0.58 | -0.46 |
| Weighted Average Shares Outstanding | 21.84 Million | 21.84 Million | 19.94 Million | 18.65 Million | 18.05 Million | 17.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.84 Million | 21.84 Million | 19.94 Million | 18.65 Million | 18.05 Million | 18.05 Million |
| Gross Margin | 0.54 | 0.55 | 0.56 | 0.55 | 0.55 | 0.50 |
| EBIT Margin | -0.04 | -0.09 | -0.04 | -0.14 | -0.14 | -0.19 |
| Profit Margin | -0.15 | -0.13 | -0.12 | -0.24 | -0.27 | -0.31 |
| EBITDA | -2.38 Million | -1.29 Million | 2.01 Million | -4.91 Million | -5.71 Million | -5.11 Million |
| Earnings Before Tax Margin | -0.12 | -0.14 | -0.20 | -0.21 | -0.15 | -0.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 13.19 Million | 27.2 Million | 12.72 Million | 55.33 Million | 14.94 Million | 13.22 Million |
| Cost of Revenue | 6.12 Million | 26.07 Million | 5.59 Million | 25.21 Million | 6.63 Million | 5.72 Million |
| Gross Profit | 7.06 Million | 1.13 Million | 7.13 Million | 30.12 Million | 8.3 Million | 7.5 Million |
| Operating Expenses | 9.34 Million | 4.78 Million | 9.32 Million | 35.7 Million | 8.25 Million | 9.17 Million |
| Selling, General and Administrative Expenses | 5.94 Million | 5.01 Million | 5.86 Million | - | 5.55 Million | 5.64 Million |
| Research and Development Expenses | - | - | - | - | 4.97 Million | - |
| Other Expenses | 125 Thousand | 232 Thousand | 117 Thousand | 118 Thousand | -558 Thousand | 277 Thousand |
| Cost and Expenses | 15.46 Million | 30.85 Million | 14.91 Million | 60.91 Million | 14.89 Million | 14.89 Million |
| Operating Income | -2.14 Million | -3.64 Million | -2.06 Million | -5.48 Million | -522 Thousand | -1.39 Million |
| Interest Expense | 621 Thousand | 458 Thousand | 389 Thousand | 858 Thousand | 288 Thousand | 3000.00 |
| Income Tax Expense | -373 Thousand | 168 Thousand | 31 Thousand | 625 Thousand | 647 Thousand | -8000.00 |
| Earnings before Tax | -2.93 Million | -4.08 Million | -2.6 Million | -7.48 Million | -1.02 Million | -1.84 Million |
| Net Income | -2.57 Million | -4.56 Million | -2.64 Million | -8.27 Million | -1.63 Million | -1.84 Million |
| Earnings Per Share Basic | -0.12 | -0.21 | -0.12 | - | -0.08 | -0.08 |
| Earnings Per Share Diluted | -0.12 | -0.21 | -0.12 | - | -0.08 | -0.08 |
| Weighted Average Shares Outstanding | 21.84 Million | 21.84 Million | 21.84 Million | 21.84 Million | 21.84 Million | 21.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.84 Million | 21.84 Million | 21.84 Million | 21.84 Million | 21.84 Million | 21.84 Million |
| Gross Margin | 0.54 | 0.04 | 0.56 | 0.54 | 0.56 | 0.57 |
| EBIT Margin | -0.09 | -0.05 | -0.08 | - | 0.04 | -0.05 |
| Profit Margin | -0.19 | -0.17 | -0.21 | -0.15 | -0.11 | -0.14 |
| EBITDA | -1.13 Million | -1.3 Million | -1.03 Million | - | 570 Thousand | -708 Thousand |
| Earnings Before Tax Margin | -0.16 | -0.13 | -0.16 | -0.10 | -0.03 | -0.11 |
PANDY
OBEL
MLVER
D7G
FSV
SYZLF